*Optimal dilutions/concentrations should be determined by the researcher.
Not tested in other applications.
HepG2 , HepG2(10 mM Nicotinamide and 0.4 mM Trichostatin A treatment for 48 hr) , HeLa mock and shFN1 , mouse plasma
Rat, Bovine, Chicken(>80% identity)
1XPBS, 1% BSA, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Recombinant protein encompassing a sequence within the N-terminus region of human Fibronectin. The exact sequence is proprietary.
Purified by antigen-affinity chromatography.
For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
CIG antibody, DKFZp686F10164 antibody, DKFZp686H0342 antibody, DKFZp686I1370 antibody, DKFZp686O13149 antibody, ED-B antibody, FINC antibody, FN antibody, FNZ antibody, GFND antibody, GFND2 antibody, LETS antibody, MSF antibody, FN1 antibody, migration-stimulating factor antibody, fibronectin antibody, cold-insoluble globulin antibody, fibronectin 1 antibody
Secreted , extracellular space , extracellular matrix
This gene encodes fibronectin, a glycoprotein present in a soluble dimeric form in plasma, and in a dimeric or multimeric form at the cell surface and in extracellular matrix. Fibronectin is involved in cell adhesion and migration processes including embryogenesis, wound healing, blood coagulation, host defense, and metastasis. The gene has three regions subject to alternative splicing, with the potential to produce 20 different transcript variants. However, the full-length nature of some variants has not been determined. [provided by RefSeq]